Clinical Trial Update: NASVAC Phase-III Trial in Chronic Hepatitis B (CHB) Patients [Phase 3]

View source ↗

Summary

This document provides an update on NASVAC, a therapeutic vaccine, being evaluated in a Phase 3 trial for chronic hepatitis B, with the current status not discl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• NASVAC

Snippet

Sponsor: Clinical Research Organization, Dhaka, Bangladesh | Conditions: Chronic Hepatitis B | Phase 3 | Status: UNKNOWN